What should be the gold standard for the surgical component in the treatment of locally advanced esophageal cancer: Transthoracic versus transhiatal esophagectomy

Annals of Surgery

Volumn 260, Issue 6, 2014, Pages 1016-1022

  Kutup, Asad ^a   Nentwich, Michael F ^a   Bollschweiler, Elfriede ^b   Bogoevski, Dean ^a   Izbicki, Jakob R ^a   Hölscher, Arnulf H ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Esophageal cancer; Esophagectomy; Locally advanced; Surgical approach; Transhiatal resection; Transthoracic resection

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; GASTROINTESTINAL STAPLER; GOLD STANDARD; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE RATIO; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROPENSITY SCORE; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SURGICAL STAPLING; SURVIVAL RATE; TRANSHIATAL ESOPHAGECTOMY; TRANSTHORACIC ESOPHAGECTOMY; CLINICAL TRIAL; EPIDEMIOLOGY; ESOPHAGEAL NEOPLASMS; GASTROINTESTINAL ENDOSCOPY; GERMANY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROCEDURES; STANDARDS; THORACOTOMY; TIME; TREATMENT OUTCOME; TRENDS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; THORACOTOMY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84922324579     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000335     Document Type: Article

References (37)

1. Orringer MB. Transhiatal esophagectomy without thoracotomy for carcinoma of the thoracic esophagus. Ann Surg. 1984;200: 282-288.
2. Portale G, Hagen JA, Peters JH, et al. Modern 5-year survival of resectable esophageal adenocarcinoma: Single institution experience with 263 patients. J Am Coll Surg. 2006;202: 588-596; discussion 596-598.
3. Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: An updated meta-Analysis. Lancet Oncol. 2011;12: 681-692.
4. vanHagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366: 2074-2084.
5. Wijnhoven BP, van Lanschot JJ, Tilanus HW, et al. Neoadjuvant chemoradiotherapy for esophageal cancer: A review of meta-Analyses. World J Surg. 2009;33: 2606-2614.
6. Walsh TN, NoonanN, Hollywood D, et al.Acomparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335: 462-467.
7. Tepper J, KrasnaMJ, Niedzwiecki D, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol. 2008;26: 1086-1092.
8. Metzger R, Bollschweiler E, Vallbohmer D, et al. High volume centers for esophagectomy: What is the number needed to achieve low postoperative mortality? Dis Esophagus. 2004;17: 310-314.
9. Sobin L, Gospodarowicz M, Wittekind C. TNM Classification of Malignant Tumors. 7th ed. New York: John Wiley & Sons; 2011.
10. Iyer RB, Silverman PM, Tamm EP, et al. Diagnosis, staging, and follow-up of esophageal cancer. AJR Am J Roentgenol. 2003;181: 785-793.
11. Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347: 1662-1669.
12. Hölscher AH, Schröder W, Gutschow C, et al. Laparoscopic ischemic conditioning of the stomach for esophageal replacement. Ann Surg. 2007;245: 241-246.
13. Schroder W, Hölscher AH, Bludau M, et al. Ivor-Lewis esophagectomy with and without laparoscopic conditioning of the gastric conduit. World J Surg. 2010;34: 738-743.
14. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70: 41-55.
15. Boshier PR, Anderson O, Hanna GB. Transthoracic versus transhiatal esophagectomy for the treatment of esophagogastric cancer: A meta-Analysis. Ann Surg. 2011;254: 894-906.
16. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349: 2241-2252.
17. Mariette C, Piessen G, Triboulet JP. Therapeutic strategies in oesophageal carcinoma: Role of surgery and other modalities. Lancet Oncol. 2007;8: 545-553.
18. Rindani R, Martin CJ, Cox MR. Transhiatal versus Ivor-Lewis oesophagectomy: Is there a difference? Aust N Z J Surg. 1999;69: 187-194.
19. Hulscher JB, Tijssen JG, Obertop H, et al. Transthoracic versus transhiatal resection for carcinoma of the esophagus: A meta-Analysis. Ann Thorac Surg. 2001;72: 306-313.
20. Lerut T, CoosemansW, De Leyn P, et al. Is there a role for radical esophagectomy. Eur J Cardiothorac Surg. 1999;16(suppl 1): S44-S47.
21. Pultrum BB, Honing J, Smit JK, et al. A critical appraisal of circumferential resection margins in esophageal carcinoma. Ann Surg Oncol. 2010;17: 812-820.
22. van Sandick JW, van Lanschot JJ, ten Kate FJ, et al. Indicators of prognosis after transhiatal esophageal resection without thoracotomy for cancer. J Am Coll Surg. 2002;194: 28-36.
23. Rizk NP, Ishwaran H, Rice TW, et al. Optimum lymphadenectomy for esophageal cancer. Ann Surg. 2010;251: 46-50.
24. Herrera LJ. Extent of lymphadenectomy in esophageal cancer: How many lymph nodes is enough? Ann Surg Oncol. 2010;17: 676-678.
25. Omloo JM, Law SY, Launois B, et al. Short and long-Term advantages of transhiatal and transthoracic oesophageal cancer resection. Eur J Surg Oncol. 2009;35: 793-797.
26. Gockel I, Heckhoff S, Messow CM, et al. Transhiatal and transthoracic resection in adenocarcinoma of the esophagus: Does the operative approach have an influence on the long-Term prognosis? World J Surg Oncol. 2005;3: 40.
27. Bollschweiler E, Baldus SE, Schroder W, et al. Staging of esophageal carcinoma: Length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors? J Surg Oncol. 2006;94: 355-363.
28. Peyre C, Hagen J, De Meester S, et al. The number of lymph nodes removed predicts survival in esophageal cancer: An international study on the impact of extent of surgical resection. Ann Surg. 2008;248: 549-556.
29. Bogoevski D, Onken F, Koenig A, et al. Is it time for a new TNM classification in esophageal carcinoma? Ann Surg. 2008;247: 633-641.
30. Bogoevski D, BockhornM, Koenig A, et al. How radical should surgery be for early esophageal cancer? World J Surg. 2011;35: 1311-1320.
31. Colvin H, Dunning J, Khan OA. Transthoracic versus transhiatal esophagectomy for distal esophageal cancer: Which is superior? Interact Cardiovasc Thorac Surg. 2011;12: 265-269.
32. Omloo JM, Lagarde SM, Hulscher JB, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: Five-year survival of a randomized clinical trial. Ann Surg. 2007;246: 992-1000; discussion 1000-1001.
33. Johansson J, DeMeester TR, Hagen JA, et al. En bloc vs transhiatal esophagectomy for stage T3 N1 adenocarcinoma of the distal esophagus. Arch Surg. 2004;139: 627-631; discussion 631-633.
34. Block MI. Transthoracic vs. transhiatal esophagectomy: Stage migration muddies the water. J Surg Oncol. 2006;93: 519-520.
35. Schurr PG, Yekebas EF, Kaifi JT, et al. Lymphatic spread and micro involvement in adenocarcinoma of the esophago-gastric junction. J Surg Oncol. 2006;94: 307-315.
36. Yekebas EF, Schurr PG, Kaifi JT, et al. Effectiveness of radical en-blocesophagectomy compared to transhiatal esophagectomy in squamous cell cancer of the esophagus is influenced by nodal micrometastases. J Surg Oncol. 2006;93: 541-549.
37. Kutup A, Link BC, Schurr PG, et al. Quality control of endoscopic ultrasound in preoperative staging of esophageal cancer. Endoscopy. 2007;39: 715-719.